Streetbeat News

BGXX

Bright Green Corporation

https://www.brightgreen.us

Industry

Drug Manufacturers - Specialty & Generic

Bright Green Corporation grows, manufactures, and sells cannabis and cannabis-related products legally under federal and state laws for research, pharmaceutical applications, and export. The company was incorporated in 2019 and is based in Fort Lauderdale, Florida.

Open

0.09

Mkt cap

17M

Volume

27K

High

0.09

P/E Ratio

-1.81

52-wk high

0.54

Low

0.08

Div yield

N/A

52-wk low

0.03

Bright Green Corporation (NASDAQ:BGXX) faces delisting from Nasdaq but is focusing on strategic growth through a reverse stock split, partnerships, and acquisitions. The company is committed to financial stability and expanding its market presence.

Portfolio Pulse from Juan Spínelli

September 23, 2024 | 5:33 pm

Bright Green Corporation (NASDAQ:BGXX) has signed a letter of intent with Benuvia Operations to supply DEA-approved marijuana extracts and plant-based psychedelics. This partnership highlights Bright Green's commitment to providing high-quality organic materials for pharmaceutical use.

Portfolio Pulse from Benzinga Newsdesk

August 23, 2024 | 2:05 pm

Bright Green Corporation (NASDAQ:BGXX) has signed a letter of intent to supply DEA-approved cannabis extracts and psychedelics to Benuvia Operations, an FDA-registered pharmaceutical company. This agreement positions Bright Green as a leading supplier of plant-based raw materials for cannabinoid, psychedelic, and opioid-based drugs in the USA.

Portfolio Pulse from Nina Zdinjak

August 22, 2024 | 3:39 pm

Bright Green has signed a Letter of Intent (LOI) to supply DEA-approved marijuana extracts and psychedelics to Benuvia Operations for pharmaceutical use. This move underscores Bright Green's commitment to partnerships within the US pharmaceutical sector.

Portfolio Pulse from Benzinga Newsdesk

August 21, 2024 | 2:03 pm

The article highlights the pre-market movements of various health care stocks on Wednesday. Notable gainers include Avidity Biosciences (NASDAQ:RNA), Molecular Partners (NASDAQ:MOLN), and Longeveron (NASDAQ:LGVN). Significant losers include ThermoGenesis Holdings (NASDAQ:THMO) and Calidi Biotherapeutics (AMEX:CLDI).

Portfolio Pulse from Benzinga Insights

June 12, 2024 | 12:06 pm

GameStop shares fell over 22% after releasing worse-than-expected Q1 results and filing to sell up to 75 million shares. The company reported net sales of $881.8 million, missing the consensus estimate of $995.3 million, and a loss of 12 cents per share, missing the estimate of a loss of 9 cents per share. Other stocks moving significantly include Trinity Place Holdings, Leafly Holdings, Venus Concept, Asensus Surgical, Faraday Future, Geron Corporation, and more.

Portfolio Pulse from Avi Kapoor

June 07, 2024 | 5:07 pm

Braze, Inc. (NASDAQ:BRZE) shares surged 14.3% in pre-market trading after reporting better-than-expected first-quarter earnings. Other notable pre-market movers include Venus Concept Inc. (NASDAQ:VERO), Versus Systems Inc. (NASDAQ:VS), GameStop Corp. (NYSE:GME), and Geron Corporation (NASDAQ:GERN). On the losing side, Biomea Fusion, Inc. (NASDAQ:BMEA) shares plummeted 59.2% after an FDA clinical hold notice.

Portfolio Pulse from Avi Kapoor

June 07, 2024 | 9:17 am

The article highlights the performance of 12 health care stocks during Thursday's after-market session. Notable gainers include Venus Concept (VERO), Cyclacel Pharmaceuticals (CYCC), and Applied DNA Sciences (APDN). Significant losers include Biomea Fusion (BMEA), Tevogen Bio Holdings (TVGN), and Bright Green (BGXX).

Portfolio Pulse from Benzinga Insights

June 06, 2024 | 8:31 pm

Lands' End, Inc. (NASDAQ:LE) shares fell 9.3% to $12.60 after reporting a quarterly adjusted loss of 20 cents per share, which beat the analyst consensus estimate of 26 cents per share. The company also reported quarterly sales of $285.47 million, surpassing the analyst consensus estimate of $269.82 million. Other notable stock movements include Actelis Networks, Inc. (NASDAQ:ASNS) jumping 512% after announcing orders for cyber-hardened networking technology, and WalkMe Ltd. (NASDAQ:WKME) gaining 42.1% after entering into a definitive agreement to be acquired by SAP.

Portfolio Pulse from Avi Kapoor

June 05, 2024 | 5:04 pm

The article highlights significant intraday movements in health care stocks on Wednesday. Notable gainers include ENDRA Life Sciences (NDRA), Rezolute (RZLT), Bright Green (BGXX), Champions Oncology (CSBR), Kineta (KA), and CVRx (CVRX). On the losing side, SILO Pharma (SILO), Concord Medical Services (CCM), FibroBiologics (FBLG), Cue Health (HLTH), GH Research (GHRS), and MAIA Biotechnology (MAIA) experienced notable declines.

Portfolio Pulse from Benzinga Insights

June 05, 2024 | 4:31 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.